Big Pharma Split Corp Class A Working Capital to Net Assets Ratio
Big Pharma Split Corp Class A working capital to net assets ratio. Big Pharma Split Corp Class A (PRM) has a Working Capital to Net Assets ratio of -63.8% as of June 2026. Working capital of CA$-12.40 Million (current assets of CA$1.29 Million minus current liabilities of CA$13.68 Million) is measured against net assets of CA$19.44 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check PRM tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Big Pharma Split Corp Class A (2017–2025)
Working capital to net assets ratio of Big Pharma Split Corp Class A from 2017 to 2025. This chart shows how Big Pharma Split Corp Class A's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the ratio stands at -63.8%, reflecting working capital of CA$-12.40 Million against net assets of CA$19.44 Million CAD. See PRM days of operational coverage to measure how many days the company can operate on defensive assets alone.
Big Pharma Split Corp Class A Working Capital to Net Assets Ratio by Year (2017–2025)
Big Pharma Split Corp Class A working capital to net assets ratio by year from 2017 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Big Pharma Split Corp Class A from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see PRM total assets.
| Year | WC/NA Ratio | Working Capital (CAD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 97.8% | CA$17.87 Million | CA$18.27 Million | CA$31.33 Million | CA$13.47 Million | ▲ +176.1 pp |
| 2024 | -78.3% | CA$-10.71 Million | CA$13.68 Million | CA$1.13 Million | CA$11.84 Million | ▼ -83.0 pp |
| 2023 | 4.7% | CA$750.86K | CA$15.85 Million | CA$999.54K | CA$248.68K | ▲ +27.8 pp |
| 2022 | -23.0% | CA$-4.54 Million | CA$19.73 Million | CA$14.82 Million | CA$19.37 Million | ▼ -28.3 pp |
| 2021 | 5.3% | CA$1.19 Million | CA$22.40 Million | CA$1.53 Million | CA$339.02K | ▲ +76.7 pp |
| 2020 | -71.4% | CA$-9.41 Million | CA$13.19 Million | CA$335.25K | CA$9.75 Million | ▼ -171.4 pp |
| 2019 | 100.0% | CA$16.31 Million | CA$16.31 Million | CA$27.18 Million | CA$10.87 Million | ▲ +0.0 pp |
| 2018 | 100.0% | CA$18.84 Million | CA$18.84 Million | CA$33.63 Million | CA$14.79 Million | ▲ +0.0 pp |
| 2017 | 100.0% | CA$18.68 Million | CA$18.68 Million | CA$32.49 Million | CA$13.81 Million | — |